Induced pluripotential stem cells and the prospects for cardiac cell therapy

Jonathan M W Slack, James R. Dutton

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This chapter explains the properties of induced pluripotential stem cells (iPS cells) and why they may represent a new dawn for cell therapy of the heart. iPS cells are very similar to embryonic stem cells (ES cells) in that they can grow without limit in tissue culture, and can form all of the cell types in the normal body. But unlike embryonic stem cells, their production requires no eggs or embryos, and can probably be achieved from any individual patient. The technology of making and using iPS cells is based entirely on knowledge gained from growing ES cells. Because ES cells represent the gold standard in performance, it is important to understand their nature and properties as background for understanding and maximizing the potential of iPS cells.

Original languageEnglish (US)
Title of host publicationCoronary Heart Disease: Clinical, Pathological, Imaging, and Molecular Profiles
Subtitle of host publicationClinical, Pathological, Imaging, and Molecular Profiles
PublisherSpringer US
Pages249-260
Number of pages12
Volume9781461414759
ISBN (Electronic)9781461414759
ISBN (Print)9781461414759, 1461414741, 9781461414742
DOIs
StatePublished - Jun 1 2013

Fingerprint Dive into the research topics of 'Induced pluripotential stem cells and the prospects for cardiac cell therapy'. Together they form a unique fingerprint.

Cite this